Selected article for: "leukemia virus and murine leukemia virus"

Title: 2016 ACVIM Forum Research Abstract Program
  • Document date: 2016_5_31
  • ID: 2y1y8jpx_489
    Snippet: Precision of the screening assay was determined using 3 samples (negative, low positive, and high positive). The intra-assay coefficient of variation (CV) ranged from 3.9% to 7.9% while the interassay CV ranged from 6.0% to 8.6%. For the confirmatory assay, the same low positive and high positives samples were used demonstrating an intra-assay CV which ranged from 3.0% to 4.7% and an inter-assay CV between 7.4% and 9.7%. No interference was obser.....
    Document: Precision of the screening assay was determined using 3 samples (negative, low positive, and high positive). The intra-assay coefficient of variation (CV) ranged from 3.9% to 7.9% while the interassay CV ranged from 6.0% to 8.6%. For the confirmatory assay, the same low positive and high positives samples were used demonstrating an intra-assay CV which ranged from 3.0% to 4.7% and an inter-assay CV between 7.4% and 9.7%. No interference was observed for either protocol at bilirubin, hemoglobin, and lipid concentrations up to 14.4 mg/dl, 550 mg/dl, and 6.4 OD 660 nm , respectively. The analytical sensitivity for FeLV p27 antigen was established at 1.7 ng/mL for inactivated whole FeLV and at 1.0 ng/mL for purified recombinant FeLV p27. Discriminating analytical specificity was demonstrated based on the absence of cross-reactivity to related retrovirus antigen from murine leukemia virus and Feline RD-114. Overall, the assay exhibited 100% diagnostic accuracy in 83 patient samples (n = 63 negative; n = 20 positive) with FeLV status defined on the combined basis of PCR (FeLV RealPCR; IDEXX Laboratories, Inc.) and independent ELISA (ViraCHEK FeLV; Zoetis, Inc.).

    Search related documents:
    Co phrase search for related documents
    • analytical sensitivity and recombinant FeLV p27: 1
    • analytical sensitivity and screening assay: 1, 2, 3, 4, 5, 6, 7
    • analytical specificity and patient sample: 1
    • analytical specificity and screening assay: 1, 2, 3
    • confirmatory assay and patient sample: 1, 2
    • confirmatory assay and screening assay: 1, 2, 3, 4, 5, 6, 7, 8
    • CV variation and screening assay: 1, 2
    • diagnostic accuracy and patient sample: 1, 2, 3, 4
    • diagnostic accuracy and screening assay: 1, 2, 3, 4
    • FeLV p27 and recombinant FeLV p27: 1
    • FeLV p27 and screening assay: 1
    • inter assay and patient sample: 1
    • inter assay and screening assay: 1
    • intra assay and patient sample: 1
    • intra assay and screening assay: 1
    • intra assay coefficient and patient sample: 1
    • leukemia virus and recombinant FeLV p27: 1
    • patient sample and screening assay: 1